Yang Ding

机构：China Pharmaceutical University, Second Military Medical University, Wuhan University, Hubei Provincial Center for Disease Control and Prevention, Changhai Hospital, Zhongnan Hospital of Wuhan University · ORCID：0000-0003-0836-7790

发表论文 38 篇 · 总被引 871 次 · h-index 14

代表论文

• Wumei Wan attenuates angiogenesis and inflammation by modulating RAGE signaling pathway in IBD: Network pharmacology analysis and experimental evidence (2023 · Phytomedicine · 被引 133)
• RETRACTED ARTICLE: Deep learning approach to predict autism spectrum disorder: a systematic review and meta-analysis (2024 · BMC Psychiatry · 被引 45)
• Mesenchymal stem cells rescue acute hepatic failure by polarizing M2 macrophages (2017 · World Journal of Gastroenterology · 被引 32)
• Early administration of Wumei Wan inhibit myeloid-derived suppressor cells via PI3K/Akt pathway and amino acids metabolism to prevent colitis-associated colorectal cancer (2024 · Journal of Ethnopharmacology · 被引 27)
• Immunohistochemistry Detects Increased Expression of Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) in Early-Stage Hepatocellular Carcinoma (2018 · Medical Science Monitor · 被引 22)
• Programmed death 1, ligand 1 and 2 correlated genes and their association with mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma (2020 · World Journal of Gastrointestinal Oncology · 被引 21)